General Information of the Compound
Compound ID |
CP0425793
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(S)-2-((2S,3S)-2-(2-((S)-1-((S)-2-((S)-2-amino-5-guanidinopentanamido)-5-guanidinopentanoyl)-N-(4-methoxyphenethyl)pyrrolidine-2-carboxamido)acetamido)-3-methylpentanamido)-4-methylpentanoic acid
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C40H68N12O8
|
||||||||||||||||||
Molecular Weight |
845.06
|
||||||||||||||||||
Canonical SMILES |
CC[C@H](C)[C@H](NC(=O)CN(CCc1ccc(OC)cc1)C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(O)=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C40H68N12O8/c1-6-25(4)33(35(55)49-30(38(58)59)22-24(2)3)50-32(53)23-51(21-17-26-13-15-27(60-5)16-14-26)37(57)31-12-9-20-52(31)36(56)29(11-8-19-47-40(44)45)48-34(54)28(41)10-7-18-46-39(42)43/h13-16,24-25,28-31,33H,6-12,17-23,41H2,1-5H3,(H,48,54)(H,49,55)(H,50,53)(H,58,59)(H4,42,43,46)(H4,44,45,47)/t25-,28-,29-,30-,31-,33-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
LGNBWJGWZXGACQ-KECVWQCXSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02429, Neurotensin receptor type 1
Protein ID: PT02626, Neurotensin receptor type 2